Your session is about to expire
← Back to Search
MS for Normal Physiology
Study Summary
This trial is studying how transcranial magnetic stimulation (TMS) of the brain may improve memory in healthy adults.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 1 & 2 trial • 92 Patients • NCT00520130Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are afraid of being in small or enclosed spaces.You have metal objects in your head or eye, or implanted devices for brain or hearing stimulation.You have a history of seizures (convulsions).You are taking medications that affect the brain and could increase the risk of seizures or have certain side effects.You have a serious brain or mental health condition like stroke, Parkinson's disease, Alzheimer's disease, schizophrenia, or severe depression.
- Group 1: MS
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being treated in this clinical trial?
"Affirmative. The trial's listing on clinicaltrials.gov states the study is currently seeking patients for participation, with 33 total enrollees needed from a single site. This medical experiment was first announced on July 9th 2021 and last amended November 10th 2022."
Are people currently being enrolled in this research endeavor?
"As reported on clinicaltrials.gov, this medication trial is presently seeking suitable participants; the initial advertisement was posted in July 2021, and further details were amended as recently as November 2022."
What are the fundamental aims of this trial?
"During this trial, the primary outcome of measure will be Late Positive Posterior ERP, recorded over about one hour. Additionally, Theta/Alpha power (Power in 4-13 Hz band 0-1000 ms after trial onset), EEG functional connectivity (Pearson correlation coefficients between electrode time courses) and DTI structural connectivity (Fractional anisotropy at baseline between hippocampus and cortical regions) will serve as secondary outcomes."
Is geriatric participation being considered in this clinical research?
"This trial is only open to people between the ages of 18 and 40, though there are other studies for both younger and elder patients. For example, 1 research program caters specifically to those under 18 years old while 7 trials accommodate individuals aged 65 or older."
Am I eligible to register for this trial?
"This trial is searching for 33 people whose physiology falls within the normal range and are between 18-40 years old. All potential participants should be willing to abide by all study procedures, sign an informed consent form, and make themselves available throughout the duration of this research project."
Share this study with friends
Copy Link
Messenger